
Washington DC: A revolutionary study by Case Western Reserve University researchers reveals that a class of medications used to treat type 2 diabetes may also lower the risk of colorectal cancer (CRC).

Washington DC: A revolutionary study by Case Western Reserve University researchers reveals that a class of medications used to treat type 2 diabetes may also lower the risk of colorectal cancer (CRC).